Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

Personal injury attorneys Phillips Law Firm analyzed the most recent available cancer figures from the CDC (from 2021), using ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Louis van Gaal has said he is "no longer bothered by cancer" and is keen for a return to the higher levels of the game.

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...

Today, the United States celebrates the anniversary of its independence from Great Britain.  Independence Day, also known as ...

Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...